We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » KING CLAIMS REMOVING FOOD INDICATION ON GENERIC SKELAXIN IS UNSAFE
KING CLAIMS REMOVING FOOD INDICATION ON GENERIC SKELAXIN IS UNSAFE
April 1, 2004
King Pharmaceuticals has blasted a recent FDA decision allowing generic firms to market versions of King’s muscle relaxant Skelaxin (metaxalone) without labeling that says taking the drug with food increases its bioavailability.